DE-127 ophthalmic solution

DE-127 ophthalmic solution · Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DE-127 ophthalmic solution, covering 2020-08-26 to 2020-08-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing the Efficacy and Safety of DE-127 Ophthalmic Solution in Subjects With Mild or Moderate Myopia (APPLE) [Phase 2]

See pricing